Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ANTIGENICS INC DEL Analyst Recommendations

  • Analyst Consensus: AGEN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 3.000 Hold 1
    30 Days Ago 3.000 Hold 1
    60 Days Ago 3.000 Hold 1
    90 Days Ago 3.000 Hold 1
    120 Days Ago 3.000 Hold 1

  • Analyst Ratings: AGEN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    UBS — Reduce 03/27/2006 2.00
    Banc of America Sec — Sell 10/18/2005 3.00
    Stanford Research Buy Hold 10/10/2005 —
    Prudential — Underweight 06/07/2005 4.00
    UBS Neutral Reduce 12/07/2004 —
    Needham & Co Hold Underperform 10/20/2004 —
    UBS — Neutral 09/24/2004 7.00
    Rodman & Renshaw — Mkt Perform 05/05/2004 —
    Needham & Co Buy Hold 04/21/2004 —
    Needham & Co — Buy 02/20/2004 23.00
    Needham & Co — Buy 10/24/2003 23.00
    Ryan, Beck & Co — Outperform 09/22/2003 —
    Needham & Co — Buy 09/04/2003 23.00
    Ryan, Beck & Co — Outperform 09/04/2003 19.00
    Needham & Co — Buy 07/24/2003 23.00
    Needham & Co — Buy 06/04/2003 23.00
    Needham & Co — Buy 02/05/2003 23.00
    Needham & Co — Buy 01/02/2003 23.00
    Ryan, Beck & Co — Outperform 12/17/2002 22.00
    Ryan, Beck & Co — Outperform 10/24/2002 22.00
    Needham & Co — Buy 10/24/2002 23.00
    Ryan, Beck & Co — Outperform 10/14/2002 22.00
    Needham & Co — Buy 09/23/2002 23.00
    UBS Warburg — Buy 08/01/2002 15.00
    Needham & Co — Buy 07/26/2002 —
    Ryan, Beck & Co — Outperform 07/25/2002 22.00
    Ryan, Beck & Co — Outperform 07/23/2002 22.00
    Needham & Co — Buy 07/23/2002 —
    Gruntal & Co — NT Mkt Outperformer 06/20/2002 22.00
    Needham & Co — Buy 06/06/2002 —
    Next